1. Physicians Data Query [Database online]. Phase II study of the progesterone antagonist mifepristone in postmenopausal patients with stage IV breast cancer. Bethesda: National Cancer Institute, 1994 Apr [cited 1994 Apr 15]; protocol accession PDQP-000758 [8 screens]. Available from: National Library of Medicine, Bethesda, Maryland, or BRS Information Technologies, McLean, Virginia.
2. Physicians Data Query [Database online]. Phase III randomized double-blind trial of mifepristone vs placebo in patients with unresectable meningioma. Bethesda: National Cancer Institute, 1994 Apr [cited 1994 Apr 15]; protocol accession PDQP-000821 [19 screens]. Available from: National Library of Medicine, Bethesda, Maryland, or BRS Information Technologies, McLean, Virginia.
3. Antitumor activity of the progesterone antagonists ZK98.299 and RU 486 in the hormone-dependent MXT mammary tumor model of the mouse and the DMBA- and MNU-induced mammary tumor model of the rat;Schneider;Eur j Cancer Clin Oncol,1989
4. Antiprogestins, a new form of endocrine therapy for human breast cancer;Klijn;Cancer Res,1989
5. Contraceptive potential of RU 486 by ovulation inhibition. I. Pituitary versus ovarian action with blockade of estrogen-induced endometrial proliferation;van Uem;Contraception,1989